Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
The New York Times - February 23, 2008
For the last 20 years, Congress has blocked the use of federal money to pay for needle exchange programs in the United States or abroad. For 10 years, Congress banned Washington from using tax dollars raised in the District of Columbia to pay for needle exchange efforts.
Congress finally lifted Washington's ban in December, stripping that provision in the federal budget that President Bush had signed. The District of Columbia has now allocated $650,000 that will, among other things, pay to open a clinic that combines needle exchanges with H.I.V. testing. In what would be an unconscionable reversal, President Bush's new budget request would reimpose that ban.
Needle exchange programs have proved highly successful around the world, and the country's most important medical and public health organizations have endorsed the efforts for more than a decade. Opponents' claims that needle exchanges would encourage addiction have turned out to be nonsense.
The nation's capital has the country's highest rate of H.I.V. infection, and a recent report by the District of Columbia's health department found that more than 20 percent of the city's AIDS cases could be traced to intravenous drug users. Now that Washington has a chance to fight back, the White House must not be allowed to hobble that effort.
Congress must insist that Washington be allowed to spend its own money on needle exchange programs. And it must begin passing budgets that allow states - and health organizations overseas - to use federal dollars for these life-saving programs.
080223
NYT080214
Copyright © 2008 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .